Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Conditions: Generalized Anxiety Disorder Interventions: Drug: Buagafuran capsules, 15mg/ capsule; Drug: Buspirone tablets, 5mg/ tablet; Drug: Buagafuran capsules mimic, 0mg/ capsule; Drug: Buspirone tablets mimic, 0mg/ tablet Sponsors: Beijing Union Pharmaceutical Factory Ltd; R&G Pharma Studies Co.,Ltd. Recruiting
Source: - Category: Research Source Type: clinical trials